Oral contraceptives may increase risk for developing gliomas
the ONA take:
According to a new study published in the British Journal of Clinical Pharmacology, researchers have found that certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
For the study, researchers analyzed data from Denmark's national registries of health records, cancer cases, and prescriptions in order to identify women aged 15 to 49 years diagnosed with glioma and which women were prescribed contraceptives.
Results showed that women who had used hormonal contraceptives (estrogen, progestin, or both) had a 50% increased risk for developing gliomas compared with those who did not take hormonal contraceptives. In addition, women who used birth control for greater than 5 years had a nearly 200% increased risk for developing gliomas.
Women taking progestin-only contraceptives were at a slightly higher risk for developing the brain cancer than those who took estrogen only or both. The researchers note that although the risk is doubled, the cancer is still rare. Specifically, among Danish women aged 15 to 49 years, only five in 100,000 will develop a glioma.
The results of the study were surprising as previous studies have found that estrogen and progestin may decrease the risk of gliomas, but particularly in post-menopausal women.
Certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|